BRIEF published on 08/27/2024 at 13:05, 1 year 6 months ago Pharnext begins liquidation proceedings Creditors Liquidation Paris Commercial Court Pharnext Suspension Of Listing
BRIEF published on 07/04/2024 at 20:05, 1 year 8 months ago Pharnext announces the termination of the financing contract granted by Néovacs Investors Termination Funding Pharnext Néovacs
BRIEF published on 06/18/2024 at 18:35, 1 year 8 months ago Pharnext announces the extension of the conciliation procedure until July 15, 2024 Pharnext Conciliation Procedure CMT1A PXT3003 Tasly
BRIEF published on 05/07/2024 at 19:15, 1 year 10 months ago Adjustment of the nominal value at Pharnext Biopharmaceutical Capital Reduction Pharnext Nominal Value Neurodegenerative Diseases
BRIEF published on 04/30/2024 at 23:50, 1 year 10 months ago Pharnext announces its 2023 results and the progress of its conciliation procedure 2023 Financial Results Pharnext Conciliation Procedure Phase III Clinical Trial Cost Control
PRESS RELEASE published on 01/04/2023 at 08:30, 3 years 2 months ago Pharnext strengthens its Senior Leadership Team with the appointment of Scott Johnson as VP, Head of Quality
Published on 03/16/2026 at 22:30, 9 hours 9 minutes ago Core Silver Intersects High-Grade Copper-Molybdenum Veins up to 7.31% Cu & 1.01% Mo Confirming Large Porphyry System at Laverdiere
Published on 03/16/2026 at 22:00, 9 hours 39 minutes ago Viemed Healthcare to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19
Published on 03/16/2026 at 21:30, 10 hours 9 minutes ago Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity
Published on 03/16/2026 at 21:00, 10 hours 39 minutes ago Amdocs Brings AI-Accelerated Application Modernization to Enterprises with NVIDIA
Published on 03/17/2026 at 07:05, 34 minutes ago Sequential™ Raises $3.5M to Build AI-Powered Discovery Platform for Multi-Omic Testing and Next-Generation Skin Health Ingredients
Published on 03/17/2026 at 07:03, 36 minutes ago Sartorius Stedim Biotech sharpens strategy with biopharma focus and sets new mid-term growth targets
Published on 03/17/2026 at 07:00, 39 minutes ago PolyPeptide publishes invitation to the annual General Meeting 2026
Published on 03/17/2026 at 07:00, 39 minutes ago Very strong business performance delivered in 2025. Continued growth expected in 2026
Published on 03/17/2026 at 06:59, 40 minutes ago Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets
Published on 03/17/2026 at 07:00, 39 minutes ago Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 13 hours 39 minutes ago Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 13 hours 41 minutes ago Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 13 hours 42 minutes ago Reporting on share buyback transactions carried out between March 9 and March 13, 2026
